about
Statin therapy in metabolic syndrome and hypertension post-JUPITER: what is the value of CRP?Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational linksMetabolic syndrome in patients with chronic obstructive pulmonary disease: frequency and relationship with systemic inflammationMetabolic Syndrome Modulates Association between Endothelial Lipase and Lipid/Lipoprotein Plasma Levels in Acute Heart Failure Patients.Diabetes is a proinflammatory state: a translational perspective.Xanthine oxidase activity is associated with risk factors for cardiovascular disease and inflammatory and oxidative status markers in metabolic syndrome: effects of a single exercise session.Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome.High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazoneMetabolic syndrome and insulin resistance: underlying causes and modification by exercise training.Novel 2,5-disubstituted-1,3,4-oxadiazoles as anti-inflammatory drugs.Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study.Calcium fructoborate helps control inflammation associated with diminished bone health.Soluble membrane attack complex in ascites in patients with liver cirrhosis without infections.Flexible marginalized models for bivariate longitudinal ordinal dataTrans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study.C-Reactive Protein: How Has JUPITER Impacted Clinical Practice?Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome.Metabolic syndrome and benign prostatic hyperplasia: evidence of a potential relationship, hypothesized etiology, and prevention.Magnesium in disease.Plasma Proteomic Signature in Overweight Girls Closely Correlates with Homeostasis Model Assessment (HOMA), an Objective Measure of Insulin Resistance.The Relationships between Metabolic Disorders (Hypertension, Dyslipidemia, and Impaired Glucose Tolerance) and Computed Tomography-Based Indices of Hepatic Steatosis or Visceral Fat Accumulation in Middle-Aged Japanese MenThe impact of long-term changes in metabolic status on cardiovascular biomarkers and microvascular endothelial function in middle-aged men: a 25-year prospective study.Association between benign prostatic hyperplasia, body mass index, and metabolic syndrome in Chinese men.Associations of erythrocyte palmitoleic acid with adipokines, inflammatory markers, and the metabolic syndrome in middle-aged and older Chinese.Association between adolescent emotional problems and metabolic syndrome: the modifying effect of C-reactive protein gene (CRP) polymorphisms.Comparison of the effect of the metabolic syndrome and multiple traditional cardiovascular risk factors on vascular function.Association of high-sensitivity C-reactive protein and uric acid with the metabolic syndrome components.Serum resistin and high sensitive CRP levels in patients with subclinical hypothyroidism before and after L-thyroxine therapyThe skinny on metabolic syndrome in adolescents.Adipocytokines as features of the metabolic syndrome determined using confirmatory factor analysisConcurrent presence of inflammation and obstructive sleep apnea exacerbates the risk of metabolic syndrome: A KoGES 6-year follow-up study.Leptin Resistance and the Neuro-Adipose Connection.Quality of Life and Sexual Health in the Aging of PCa Survivors.The Metabolic Syndrome, Inflammation, and Colorectal Cancer Risk: An Evaluation of Large Panels of Plasma Protein Markers Using Repeated, Prediagnostic Samples.Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases.Obesity, weight loss and conditional cardiovascular risk factors.Cardiovascular metabolic syndrome: mediators involved in the pathophysiology from obesity to coronary heart disease.The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH).Role of inflammation in the association between the western dietary pattern and metabolic syndrome among Lebanese adults.Neurovascular Unit Dysfunction and Blood-Brain Barrier Hyperpermeability Contribute to Schizophrenia Neurobiology: A Theoretical Integration of Clinical and Experimental Evidence.
P2860
Q24602803-987B6D30-7FB6-47E9-AD30-DE016DF5A8EAQ26782663-5D90FC7E-16C4-47AB-BC04-F3E446EAC14FQ33554524-E9128A4E-9736-4B7D-A31D-30DD17A5BE72Q33681949-9501162A-9605-4959-A700-582AAABEEFB6Q33693974-6C646A33-9124-4B65-A3FF-8F0DCF6C475CQ33747411-7F51A444-DAC8-4ECD-B16B-172E5D0B9535Q33788524-0F183E19-F98A-4790-BC42-F74E642DAEC7Q33979763-BB2D9782-BCE2-4018-A4A6-39F6C3593639Q34031701-7C084914-E691-424F-B48C-E65807A20FBCQ34247656-B9077177-9B2A-481A-8D76-6EC355CE0238Q34252237-EF74FC4D-7B29-4671-B3FB-76F2DFF0E267Q34367073-450E9B76-93EC-4AE2-BA6E-93582DB5C728Q34391615-FE28AB43-5BE9-418E-9099-B2087EA92D2CQ34568101-9FABBB2F-DD11-422B-A10E-38CD7270D36EQ34667064-23962FA8-30EC-4559-BBCE-DFB7A73878D2Q34986430-B313CFA2-6521-4555-8BE5-2EFA7FAAAE27Q34997524-C7A5D222-B005-4A39-A72C-0A297E18B67DQ35182377-2BF3AFDB-82B3-4F3D-98B4-7A5B69FE0D79Q35683765-B0E3F67F-30EE-4497-B0CE-F2E603655065Q35841685-A8F971B3-FED3-4FA7-B967-A2D38C6554E6Q35944688-60C0F79D-96CA-42A9-B0D2-8DD361F3C956Q36069389-9EE87DEA-8D50-4945-8D2E-BC64AF787435Q36080363-758EFE79-C1B8-4084-BA3A-7D43EF559272Q36317134-7A40451C-BCDF-43C4-A533-C62954A8D8E5Q36406719-13C7690B-2CC8-4649-AC43-4BBB8D1EC979Q36512836-15CC151C-9B70-4EDC-88EB-88AE43F8B6A8Q36650743-8C3A8D69-47F3-4D54-BCA0-42BEC65FAE31Q36772021-FB762E35-40EE-44CC-9720-CF5AA6E99172Q36864848-836ECD35-232B-41EC-A97E-8D6EF96B6E03Q37185489-320A842D-338B-43DA-984B-B15DC35C5957Q37656228-6FD1BCC2-EA01-4B43-8A50-D102046557BAQ37681152-4F0E257F-3368-4AE6-BF72-303E487F7E4BQ37686901-7D3EBE04-B491-4B08-8A07-A2174793D875Q37738141-3CD4FB60-31B3-4846-A649-26CDE5B611C2Q37800819-294C5A64-FF88-47F2-B880-5FC691750FE8Q37807515-EF85AEB9-A9D0-449E-B79B-976BF7A86132Q37980497-DB753B51-63C8-49C6-9839-5B4C9ED3F30CQ38104737-9081CDE6-526C-4E4A-BB47-E3D3661481BCQ38728696-D2523A63-FE5B-47E5-B658-7708E4682560Q38739624-7FFBA0AB-E365-4DCA-BE96-DF70E0D31328
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Human C-reactive protein and the metabolic syndrome.
@ast
Human C-reactive protein and the metabolic syndrome.
@en
Human C-reactive protein and the metabolic syndrome.
@nl
type
label
Human C-reactive protein and the metabolic syndrome.
@ast
Human C-reactive protein and the metabolic syndrome.
@en
Human C-reactive protein and the metabolic syndrome.
@nl
prefLabel
Human C-reactive protein and the metabolic syndrome.
@ast
Human C-reactive protein and the metabolic syndrome.
@en
Human C-reactive protein and the metabolic syndrome.
@nl
P2093
P2860
P1476
Human C-reactive protein and the metabolic syndrome.
@en
P2093
Ishwarlal Jialal
Sridevi Devaraj
P2860
P304
P356
10.1097/MOL.0B013E32832AC03E
P577
2009-06-01T00:00:00Z